Literature DB >> 21440359

Trichomoniasis: evaluation to execution.

Djana F Harp1, Indrajit Chowdhury.   

Abstract

Trichomoniasis is the most common sexually transmitted disease, caused by a motile flagellate non-invasive parasitic protozoan, Trichomonas vaginalis (T. vaginalis). More than 160 million people worldwide are annually infected by this protozoan. T. vaginalis occupies an extracellular niche in the complex human genito-urinary environment (vagina, cervix, penis, prostate gland, and urethra) to survive, multiply and evade host defenses. T. vaginalis (strain G3) has a ∼160 megabase genome with 60,000 genes, the largest number of genes ever identified in protozoans. The T. vaginalis genome is a highly conserved gene family that encodes a massive proteome with one of the largest coding (expressing ∼4000 genes) capacities in the trophozoite stage, and helps T. vaginalis to adapt and survive in diverse environment. Based on recent developments in the field, we review T. vaginalis structure, patho-mechanisms, parasitic virulence, and advances in diagnosis and therapeutics.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21440359      PMCID: PMC4888369          DOI: 10.1016/j.ejogrb.2011.02.024

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  43 in total

Review 1.  Trichomoniasis.

Authors:  Jane R Schwebke; Donald Burgess
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  Trichomonas vaginalis initiator binding protein (IBP39) and RNA polymerase II large subunit carboxy terminal domain interaction.

Authors:  Audrey O T Lau; Alias J Smith; Mark T Brown; Patricia J Johnson
Journal:  Mol Biochem Parasitol       Date:  2006-07-13       Impact factor: 1.759

Review 3.  Regulation of gene expression in protozoa parasites.

Authors:  Consuelo Gomez; M Esther Ramirez; Mercedes Calixto-Galvez; Olivia Medel; Mario A Rodríguez
Journal:  J Biomed Biotechnol       Date:  2010-03-02

4.  Cysteine proteinase 30 (CP30) and antibody response to CP30 in serum and vaginal washes of symptomatic and asymptomatic Trichomonas vaginalis-infected women.

Authors:  M Yadav; M L Dubey; I Gupta; N Malla
Journal:  Parasite Immunol       Date:  2007-07       Impact factor: 2.280

5.  High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management.

Authors:  Jane R Schwebke; Edward W Hook
Journal:  J Infect Dis       Date:  2003-07-10       Impact factor: 5.226

6.  Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard.

Authors:  Nancy K Lowe; Jeremy L Neal; Nancy A Ryan-Wenger
Journal:  Obstet Gynecol       Date:  2009-01       Impact factor: 7.661

Review 7.  Metronidazole is still the drug of choice for treatment of anaerobic infections.

Authors:  Sonja Löfmark; Charlotta Edlund; Carl Erik Nord
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

8.  Diverse realities: sexually transmitted infections and HIV in India.

Authors:  S Hawkes; K G Santhya
Journal:  Sex Transm Infect       Date:  2002-04       Impact factor: 3.519

Review 9.  Trichomoniasis: under control or undercontrolled?

Authors:  David Soper
Journal:  Am J Obstet Gynecol       Date:  2004-01       Impact factor: 8.661

10.  Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis.

Authors:  Jane M Carlton; Robert P Hirt; Joana C Silva; Arthur L Delcher; Michael Schatz; Qi Zhao; Jennifer R Wortman; Shelby L Bidwell; U Cecilia M Alsmark; Sébastien Besteiro; Thomas Sicheritz-Ponten; Christophe J Noel; Joel B Dacks; Peter G Foster; Cedric Simillion; Yves Van de Peer; Diego Miranda-Saavedra; Geoffrey J Barton; Gareth D Westrop; Sylke Müller; Daniele Dessi; Pier Luigi Fiori; Qinghu Ren; Ian Paulsen; Hanbang Zhang; Felix D Bastida-Corcuera; Augusto Simoes-Barbosa; Mark T Brown; Richard D Hayes; Mandira Mukherjee; Cheryl Y Okumura; Rachel Schneider; Alias J Smith; Stepanka Vanacova; Maria Villalvazo; Brian J Haas; Mihaela Pertea; Tamara V Feldblyum; Terry R Utterback; Chung-Li Shu; Kazutoyo Osoegawa; Pieter J de Jong; Ivan Hrdy; Lenka Horvathova; Zuzana Zubacova; Pavel Dolezal; Shehre-Banoo Malik; John M Logsdon; Katrin Henze; Arti Gupta; Ching C Wang; Rebecca L Dunne; Jacqueline A Upcroft; Peter Upcroft; Owen White; Steven L Salzberg; Petrus Tang; Cheng-Hsun Chiu; Ying-Shiung Lee; T Martin Embley; Graham H Coombs; Jeremy C Mottram; Jan Tachezy; Claire M Fraser-Liggett; Patricia J Johnson
Journal:  Science       Date:  2007-01-12       Impact factor: 47.728

View more
  31 in total

1.  Trichomoniasis in older individuals: a preliminary report from Iran.

Authors:  Zohreh Momeni; Javid Sadraei; Bahram Kazemi; Abdolhossein Dalimi
Journal:  J Parasit Dis       Date:  2016-01-12

Review 2.  Strategies for Prevention and Treatment of Trichomonas vaginalis Infections.

Authors:  Kawthar Bouchemal; Christian Bories; Philippe M Loiseau
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  In Vitro Study of the Susceptibility of Clinical Isolates of Trichomonas vaginalis to Metronidazole and Secnidazole.

Authors:  Arindam P Ghosh; Cheri Aycock; Jane R Schwebke
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

4.  Epidemiology and treatment of trichomoniasis.

Authors:  Patricia Kissinger
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

Review 5.  Male infertility: a public health issue caused by sexually transmitted pathogens.

Authors:  Fabrícia Gimenes; Raquel P Souza; Jaqueline C Bento; Jorge J V Teixeira; Silvya S Maria-Engler; Marcelo G Bonini; Marcia E L Consolaro
Journal:  Nat Rev Urol       Date:  2014-10-21       Impact factor: 14.432

6.  Hydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against Trichomonas vaginalis.

Authors:  Natalia Mallo; Jesús Lamas; José M Leiro
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

Review 7.  Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure.

Authors:  Ewelina Mielczarek; Joanna Blaszkowska
Journal:  Infection       Date:  2015-11-06       Impact factor: 3.553

Review 8.  Role of Vaginal Microbiota Dysbiosis in Gynecological Diseases and the Potential Interventions.

Authors:  Yiwen Han; Zhaoxia Liu; Tingtao Chen
Journal:  Front Microbiol       Date:  2021-06-18       Impact factor: 5.640

9.  When a Ciliate Meets a Flagellate: A Rare Case of Colpoda spp. and Colpodella spp. Isolated from the Urine of a Human Patient. Case Report and Brief Review of Literature.

Authors:  Vlad S Neculicioiu; Ioana A Colosi; Dan A Toc; Andrei Lesan; Carmen Costache
Journal:  Biology (Basel)       Date:  2021-05-27

Review 10.  Trichomoniasis and lactoferrin: future prospects.

Authors:  Rakesh Sehgal; Kapil Goyal; Alka Sehgal
Journal:  Infect Dis Obstet Gynecol       Date:  2012-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.